Latest filing published 07 May 2024 for Medicine Man Technologies, Inc..
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Forrest Hoffmaster is a declared insider of Medicine Man Technologies, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 21 November 2023 to 3 May 2024, the count stands at 4 filings.
No open-market sale appears; the market trades are 3 purchases worth €13k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 1 share grant. So far in 2024, the count stands at 3 purchases and no sales.
Half of the purchases are above €4,296 and half below. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. After 3 purchases with a full 90-day history, the hit rate stands at 0% and the median 90-day move at -11.3%. Past outcomes like these are no guarantee of what comes next.
Most recently, on 7 May 2024, the filings show a share grant in Medicine Man Technologies, Inc. The last insider purchase was made public on 16 January 2024, 1,012 days ago. Typically, a trade is published a median of 49 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations